Company / Net Income
Oric Pharmaceuticals, Inc. Net Income History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$129.5M
FY2025
5-year range
-$129.5M / -$78.7M
FY2021-FY2025
Trend
-1.3%
vs FY2024
Sector context
#117 of 216
Health Care
What the data says
At -$129M, Oric Pharmaceuticals, Inc.'s net income ranks #117 of 216 in the Health Care sector. Net Income has declined for 7 consecutive years, from -$21M in FY2018 to -$129M in FY2025.
Based on SEC 10-K filings.
-$129M in FY2025.
Declined from -$101M to -$129M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#117 of 216 in Health CareTop 54% of 216This company -$129.5M Sector average $454.3M
▼
-128.5% below sector average
Key checks
Key Insights
- Oric Pharmaceuticals, Inc.'s net income has declined for 7 consecutive years.
- In FY2025, net income decreased 1.3% year-over-year.
- Ranks #117 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score 5.96 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$129.5M | -1.3% |
| FY2024 | -$127.8M | -27.0% |
| FY2023 | -$100.7M | -13.0% |
| FY2022 | -$89.1M | -13.2% |
| FY2021 | -$78.7M | -6.8% |
| FY2020 | -$73.7M | -174.2% |
| FY2019 | -$26.9M | -25.8% |
| FY2018 | -$21.4M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026